Company Participants Conference Call Participants Operator Before we commence, I would like to draw your attention to the fact that our discussion today may include forward-looking statements. These statements are subject to various risks and uncertainties that could cause actual results to differ materially from what we express or imply. We strongly encourage you to review our filings with the Securities and Exchange Commission for a comprehensive discussion of these risks and uncertainties. IPA remains co ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Conference Call March 16, 2023 10:30 AM ET Company Participants Jennifer Bath - CEO Barry Duplantis - VP-Client Relations Ilse Roodink - Chief Scientific Officer Brad McConn - CFO Conference Call Participants Will McHale - Ingalls & Snyder Swayampakula Ramakanth - H.C. Wainright Michael Freeman - Raymond James Operator Good morning, and welcome to IPA's Earnings Call for the Third Quarter Fiscal Year 2023. I am Regina, and I will be your host for t ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2023 Earnings Conference Call December 15, 2022 10:30 AM ET Company Participants Jennifer Bath – Chief Executive Officer Barry Duplantis – Vice President-Client Relations Ilse Roodink – Chief Scientific Officer Brad McConn – Chief Financial Officer Conference Call Participants Swayampakula Ramakanth – H.C. Wainwright Michael Freeman – Raymond James Will McHale – Ingalls & Snyder Operator Good morning and thank your standing by. Welcome to ImmunoPrecise Antibody ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2023 Earnings Conference Call September 14, 2022 10:30 AM ET Company Participants Jennifer Bath - President & CEO Brad McConn - CFO Ilse Roodink - Chief Scientific Officer Barry Duplantis - VP, Client Relations Operator Good morning, and thank you for standing by. Welcome to ImmunoPrecise Antibodies First Quarter Fiscal 2022 Earnings Conference Call. Also on the call with us today are Jennifer Bath, Chief Executive Officer; Brad McConn, Chief Financial Officer; ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2022 Earnings Conference Call March 16, 2022 10:30 AM ET Corporate Participants John Mullaly - IR Jennifer Bath - President and Chief Executive Officer Lisa Helbling - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to ImmunoPrecise Antibodies Fiscal Year 2022 Third Quarter Earnings Results and Business Highlights Call. Currently, all participants are in a listen-only mode. ...

The previously observed high viral clearance efficacy of TATX-03 in SARS-CoV-2-D614G-challenged hamsters implied a concerted action of the respective antibodies. Apart from anti-viral effects resulting from blocking host cell infection via synergistic effects, the demonstrated ability of TATX-03 to simultaneously bind to four different regions of the spike trimer is anticipated to promote viral clearance by the host's immune system. Recently obtained in vitro studies support this role of antibody-mediated c ...

ImmunoPrecise Antibodies - InnovationAccelerated 1 Investor Presentation December 2021 immunoprecise.com | NASDAQ:IPA, TSXV:IPA Disclosures 2 Disclaimer This presentation is not, & nothing in it should be construed as, an offer, invitation or recommendation in respect of ImmunoPrecise Antibodies Ltd. (the "Company") securities, or an offer, invitation or recommendation to sell, or solicitation of an offer to buy, the facilities or of the Company's securities in any jurisdiction. Neither this presentation no ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2022 Earnings Conference Call December 13, 2021 4:30 PM ET Company Participants Chris Chu - Johnson, Spellman & Associates, Inc., IR Dr. Jennifer Bath - President and CEO Lisa Helbling - Chief Financial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ImmunoPrecise Antibodies Fiscal Year 2022 Second Quarter Earnings Results and Business Highlights Call. At this time, all participants ar ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2022 Earnings Conference Call September 9, 2021 4:30 PM ET Company Participants John Mullaly - Investor Relations Jennifer Bath - President and Chief Executive Officer Lisa Helbling - Chief Financial Officer Operator Greetings. Thank you for standing by. Welcome to the ImmunoPrecise First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note this conference is being recorded. I will now turn the ...

Exhibit 99.2 IMMUNOPRECISE ANTIBODIES LTD. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the three months ended July 31, 2021 and 2020 | | | Three months ended July 31, | | | --- | --- | --- | --- | | | | 2021 | 2020 | | (in thousands, except share data) | Note | $ | $ | | REVENUE | | 4,588 | 3,765 | | COST OF SALES | | 2,082 | 1,355 | | GROSS PROFIT | | 2,506 | 2,410 | | EXPENSES | | | | | Advertising | | 163 | 33 | | Amortization and depreciation | 8, 9 | 670 | 678 | | Bad debt expense (recovery ...